COMPANY NAME |
REVENUES 12 Months Ending Q1 2024 |
MARKET SHARE 12 Months Q1 2024 |
MARKET SHARE MRQ Q1 2024 |
MARKET SHARE A Quarter Before Q4 2023 |
Actavia Life Sciences Inc |
0.12 |
0.00% |
0.00 % |
0.00 % |
Johnson and Johnson |
89,331.00 |
12.57% |
12.75% |
12.30% |
Merck and Co Inc |
63,922.00 |
9.00% |
9.05% |
8.53% |
Pfizer Inc |
62,463.00 |
8.79% |
7.99% |
9.70% |
Abbvie Inc |
57,367.00 |
8.07% |
7.77% |
8.25% |
Sanofi |
49,599.72 |
6.98% |
6.98% |
0.00% |
Eli Lilly And Company |
49,003.20 |
6.90% |
7.42% |
7.39% |
Bristol myers Squibb Company |
47,636.00 |
6.71% |
6.53% |
6.74% |
Novartis Ag |
46,660.00 |
6.57% |
6.57% |
0.00% |
Astrazeneca Plc |
45,811.00 |
6.45% |
6.45% |
0.00% |
Amgen Inc |
33,424.00 |
4.70% |
5.29% |
4.64% |
Takeda Pharmaceutical Company Limited |
29,166.69 |
4.11% |
4.11% |
0.00% |
Gilead Sciences Inc |
28,735.00 |
4.04% |
3.88% |
4.13% |
Teva Pharmaceutical Industries Limited |
16,617.00 |
2.34% |
2.27% |
2.31% |
Viatris Inc |
14,330.20 |
2.02% |
1.90% |
1.93% |
Regeneron Pharmaceuticals Inc |
14,085.70 |
1.98% |
1.76% |
2.07% |
Vertex Pharmaceuticals Inc |
11,099.70 |
1.56% |
1.61% |
1.59% |
Biogen Inc |
9,816.40 |
1.38% |
1.42% |
1.34% |
Bausch Health Companies Inc |
9,731.00 |
1.37% |
1.32% |
1.40% |
Organon and Co |
6,294.00 |
0.89% |
0.88% |
0.87% |
Biontech Se |
4,277.28 |
0.60% |
0.60% |
0.00% |
Jazz Pharmaceuticals Plc |
4,064.81 |
0.57% |
0.52% |
0.59% |
Horizon Therapeutics Public Limited Company |
3,643.45 |
0.51% |
0.55% |
0.45% |
Moderna Inc |
3,177.00 |
0.45% |
0.06% |
0.53% |
Royalty Pharma Plc |
2,263.85 |
0.32% |
0.33% |
0.32% |
Novavax inc |
1,254.96 |
0.18% |
0.39% |
0.05% |
Emergent Biosolutions Inc |
965.40 |
0.14% |
0.13% |
0.11% |
Biohaven Ltd |
859.68 |
0.12% |
0.00% |
0.00% |
Opko Health Inc |
713.14 |
0.10% |
0.11% |
0.09% |
Kiniksa Pharmaceuticals International Plc |
481.17 |
0.07% |
0.08% |
0.07% |
Innoviva Inc |
408.35 |
0.06% |
0.05% |
0.05% |
Myovant Sciences Ltd |
379.11 |
0.05% |
0.06% |
0.06% |
Mannkind Corporation |
297.60 |
0.04% |
0.05% |
0.04% |
Dynavax Technologies Corporation |
294.62 |
0.04% |
0.04% |
0.04% |
Galapagos Nv |
268.49 |
0.04% |
0.04% |
0.00% |
Esperion Therapeutics Inc |
259.57 |
0.04% |
0.04% |
0.04% |
Puma Biotechnology Inc |
232.71 |
0.03% |
0.03% |
0.03% |
Fibrogen Inc |
180.01 |
0.03% |
0.00% |
0.00% |
Arcturus Therapeutics Holdings Inc |
143.68 |
0.02% |
0.02% |
0.01% |
Arcus Biosciences Inc |
141.00 |
0.02% |
0.02% |
0.01% |
Siga Technologies Inc |
120.33 |
0.02% |
0.00% |
0.04% |
Curevac N v |
60.21 |
0.01% |
0.01% |
0.00% |
Fortress Biotech Inc |
57.78 |
0.01% |
0.01% |
0.01% |
Alpine Immune Sciences Inc |
56.52 |
0.01% |
0.00% |
0.02% |
Journey Medical Corp |
56.13 |
0.01% |
0.01% |
0.01% |
Aquestive Therapeutics Inc |
54.23 |
0.01% |
0.01% |
0.01% |
Integrated Biopharma Inc |
53.38 |
0.01% |
0.01% |
0.01% |
Spero Therapeutics Inc |
44.58 |
0.01% |
0.00% |
0.01% |
Hookipa Pharma inc |
43.95 |
0.01% |
0.00% |
0.00% |
Xoma Royalty Corporation |
42.91 |
0.01% |
0.01% |
0.00% |
Mei Pharma Inc |
41.67 |
0.01% |
0.00% |
0.00% |
Mirati Therapeutics Inc |
38.19 |
0.01% |
0.01% |
0.01% |
Agios Pharmaceuticals Inc |
36.50 |
0.01% |
0.01% |
0.00% |
Mereo Biopharma Group Plc |
36.46 |
0.01% |
0.00% |
0.00% |
Sunshine Biopharma Inc |
34.87 |
0.00% |
0.01% |
0.00% |
Elicio Therapeutics Inc |
29.70 |
0.00% |
0.00% |
0.00% |
Casi Pharmaceuticals inc |
28.54 |
0.00% |
0.00% |
0.00% |
Bicycle Therapeutics Plc |
25.72 |
0.00% |
0.01% |
0.00% |
Allarity Therapeutics Inc |
23.79 |
0.00% |
0.00% |
0.00% |
Medicure Inc |
16.78 |
0.00% |
0.00% |
0.00% |
Iterum Therapeutics Plc |
14.32 |
0.00% |
0.00% |
0.00% |
Aptevo Therapeutics Inc |
12.99 |
0.00% |
0.00% |
0.00% |
Immunome Inc |
12.51 |
0.00% |
0.00% |
0.00% |
Vbi Vaccines Inc |
9.41 |
0.00% |
0.00% |
0.00% |
Xbiotech Inc |
8.21 |
0.00% |
0.00% |
0.00% |
Verrica Pharmaceuticals Inc |
7.18 |
0.00% |
0.00% |
0.00% |
Dianthus Therapeutics Inc |
6.52 |
0.00% |
0.00% |
0.00% |
Arbutus Biopharma Corp |
6.17 |
0.00% |
0.00% |
0.00% |
Vtv Therapeutics Inc |
5.02 |
0.00% |
0.00% |
0.00% |
Matinas Biopharma Holdings Inc |
4.28 |
0.00% |
0.00% |
0.00% |
Abeona Therapeutics Inc |
4.25 |
0.00% |
0.00% |
0.00% |
Prometheus Biosciences Inc |
4.00 |
0.00% |
0.00% |
0.00% |
Ayala Pharmaceuticals Inc |
3.74 |
0.00% |
0.00% |
0.00% |
Dmk Pharmaceuticals Corporation |
3.53 |
0.00% |
0.00% |
0.00% |
Xenetic Biosciences Inc |
2.58 |
0.00% |
0.00% |
0.00% |
Infinity Pharmaceuticals Inc |
2.57 |
0.00% |
0.00% |
0.00% |
Palatin Technologies Inc |
2.18 |
0.00% |
0.00% |
0.00% |
Ibio inc |
2.11 |
0.00% |
0.00% |
0.00% |
Aptinyx Inc |
1.75 |
0.00% |
0.00% |
0.00% |
Humanigen Inc |
1.70 |
0.00% |
0.00% |
0.00% |
Leap Therapeutics Inc |
1.50 |
0.00% |
0.00% |
0.00% |
Immuron Limited |
1.48 |
0.00% |
0.00% |
0.00% |
Bellicum Pharmaceuticals Inc |
1.48 |
0.00% |
0.00% |
0.00% |
Hcw Biologics Inc |
1.45 |
0.00% |
0.00% |
0.00% |
Therapeuticsmd Inc |
1.41 |
0.00% |
0.00% |
0.00% |
An2 Therapeutics Inc |
1.35 |
0.00% |
0.00% |
0.00% |
Timber Pharmaceuticals Inc |
0.88 |
0.00% |
0.00% |
0.00% |
Soligenix inc |
0.85 |
0.00% |
0.00% |
0.00% |
Provectus Biopharmaceuticals Inc |
0.63 |
0.00% |
0.00% |
0.00% |
Vyne Therapeutics Inc |
0.61 |
0.00% |
0.00% |
0.00% |
Eterna Therapeutics Inc |
0.58 |
0.00% |
0.00% |
0.00% |
Imunon Inc |
0.50 |
0.00% |
0.00% |
0.00% |
Aptorum Group Limited |
0.43 |
0.00% |
0.00% |
0.00% |
Geovax Labs Inc |
0.36 |
0.00% |
0.00% |
0.00% |
Altamira Therapeutics Ltd |
0.31 |
0.00% |
0.00% |
0.00% |
Oragenics Inc |
0.22 |
0.00% |
0.00% |
0.00% |
Regen Biopharma Inc |
0.15 |
0.00% |
0.00% |
0.00% |
Innovation1 Biotech Inc |
0.08 |
0.00% |
0.00% |
0.00% |
Inflarx N v |
0.07 |
0.00% |
0.00% |
0.00% |
Serina Therapeutics Inc |
0.06 |
0.00% |
0.00% |
0.00% |
Altimmune inc |
0.02 |
0.00% |
0.00% |
0.00% |
Nascent Biotech Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Abivax Sa |
0.00 |
0.00% |
0.00% |
0.00% |
180 Life Sciences Corp |
0.00 |
0.00% |
0.00% |
0.00% |
Briacell Therapeutics Corp |
0.00 |
0.00% |
0.00% |
0.00% |
Innovation Pharmaceuticals Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Globestar Therapeutics Corporation |
0.00 |
0.00% |
0.00% |
0.00% |
Indaptus Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Nkarta Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Pardes Biosciences Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Transcode Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Renovorx Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Reviva Pharmaceuticals Holdings Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Rayzebio Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Scopus Biopharma Inc |
0.00 |
0.00% |
0.00% |
0.00% |
60 Degrees Pharmaceuticals Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Third Harmonic Bio Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Tiziana Life Sciences Ltd |
0.00 |
0.00% |
0.00% |
0.00% |
Tempest Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Vaxxinity Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Vincerx Pharma Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Contrafect Corporation |
0.00 |
0.00% |
0.00% |
0.00% |
Medicinova Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Moonlake Immunotherapeutics |
0.00 |
0.00% |
0.00% |
0.00% |
Xtl Biopharmaceuticals Ltd |
0.00 |
0.00% |
0.00% |
0.00% |
Biovie Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Vera Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Astria Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Dice Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Ventyx Biosciences Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Lianbio |
0.00 |
0.00% |
0.00% |
0.00% |
Azitra Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Acelyrin Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Nexien Biopharma Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Protokinetix Incorporated |
0.00 |
0.00% |
0.00% |
0.00% |
Viracta Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Biophytis Sa |
0.00 |
0.00% |
0.00% |
0.00% |
Galecto Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Protagenic Therapeutics Inc new |
0.00 |
0.00% |
0.00% |
0.00% |
Satsuma Pharmaceuticals Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Connect Biopharma Holdings Limited |
0.00 |
0.00% |
0.00% |
0.01% |
Calcimedica Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Cellectar Biosciences Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Edesa Biotech Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Mineralys Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Structure Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Arrivent Biopharma inc |
0.00 |
0.00% |
0.00% |
0.00% |
Contineum Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Os Therapies Incoporated |
0.00 |
0.00% |
0.00% |
0.00% |
Biostax Corp |
0.00 |
0.00% |
0.00% |
0.00% |
Precigen Inc |
-2.19 |
0.00% |
0.00% |
0.00% |
SUBTOTAL |
710,428.09 |
100% |
171,658.35 |
100% |
RASP's Market share relative to its competitors, as of Q1 2024 within the Major Pharmaceutical Preparations Industry
RASP's Market share relative to its competitors, as of Q1 2024 within the Healthcare Sector
Note: Market share is calculated based on total revenue. To get a more accurate picture of Actavia Life Sciences Inc's market divisions, geographic dispersion, segments, products, and services, visit
Actavia Life Sciences Inc's Business Segment.
The list includes publicly traded companies only. More information about the sources of this report can be found
here.